| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The International HIV Dementia Scale: a new rapid screening test for HIV dementia.
|
AIDS
|
2005
|
4.48
|
|
2
|
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
|
AIDS
|
2009
|
2.88
|
|
3
|
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.
|
AIDS
|
2011
|
1.90
|
|
4
|
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.
|
BMC Psychiatry
|
2010
|
1.73
|
|
5
|
Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia.
|
J Virol
|
2005
|
1.65
|
|
6
|
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.
|
Clin Infect Dis
|
2009
|
1.64
|
|
7
|
Clinical validation of the NeuroScreen.
|
J Neurovirol
|
2005
|
1.57
|
|
8
|
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
|
J Infect Dis
|
2013
|
1.42
|
|
9
|
Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.
|
AIDS
|
2009
|
1.40
|
|
10
|
Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective.
|
Eur J Paediatr Neurol
|
2006
|
1.31
|
|
11
|
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
|
AIDS
|
2007
|
1.25
|
|
12
|
Gene expression profiling of the preclinical scrapie-infected hippocampus.
|
Biochem Biophys Res Commun
|
2005
|
1.21
|
|
13
|
Isotope ratios of H, C, and O in CO2 and H2O of the martian atmosphere.
|
Science
|
2013
|
1.15
|
|
14
|
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells.
|
Hum Mol Genet
|
2006
|
1.14
|
|
15
|
Identification of Plet-1 as a specific marker of early thymic epithelial progenitor cells.
|
Proc Natl Acad Sci U S A
|
2008
|
1.13
|
|
16
|
HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand.
|
Int J Med Sci
|
2006
|
1.04
|
|
17
|
HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity.
|
Nat Clin Pract Neurol
|
2007
|
1.03
|
|
18
|
Construction of a large scale integrated map of macrophage pathogen recognition and effector systems.
|
BMC Syst Biol
|
2010
|
0.98
|
|
19
|
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
|
J Neurovirol
|
2013
|
0.95
|
|
20
|
Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium.
|
J Virol Methods
|
2004
|
0.92
|
|
21
|
Global NeuroAIDS roundtable.
|
J Neurovirol
|
2013
|
0.92
|
|
22
|
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment.
|
Neurology
|
2012
|
0.91
|
|
23
|
Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production.
|
Immunol Cell Biol
|
2011
|
0.85
|
|
24
|
NeuroAIDS in the Asia Pacific Region.
|
J Neurovirol
|
2008
|
0.84
|
|
25
|
Survival of a tertiary relict species, Liriodendron chinense (Magnoliaceae), in southern China, with special reference to village fengshui forests.
|
Am J Bot
|
2013
|
0.84
|
|
26
|
Motor based assessment of neurocognitive functioning in resource-limited international settings.
|
J Clin Exp Neuropsychol
|
2007
|
0.83
|
|
27
|
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda.
|
Metab Brain Dis
|
2014
|
0.82
|
|
28
|
Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda.
|
J Neurovirol
|
2013
|
0.82
|
|
29
|
Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.
|
J Neurovirol
|
2011
|
0.81
|
|
30
|
Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.
|
J Acquir Immune Defic Syndr
|
2014
|
0.80
|
|
31
|
Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon.
|
J Interferon Cytokine Res
|
2002
|
0.80
|
|
32
|
Factors that are associated with injury to the inferior alveolar nerve in high-risk patients after removal of third molars.
|
Br J Oral Maxillofac Surg
|
2013
|
0.79
|
|
33
|
Evolving clinical phenotypes in HIV-associated neurocognitive disorders.
|
Curr Opin HIV AIDS
|
2014
|
0.79
|
|
34
|
Phenology of temperate trees in tropical climates.
|
Int J Biometeorol
|
2005
|
0.79
|
|
35
|
Longitudinal characterization of depression and mood states beginning in primary HIV infection.
|
AIDS Behav
|
2014
|
0.78
|
|
36
|
Meeting review: Bioinformatics of biochips: accelerating discovery in functional genomics.
|
Comp Funct Genomics
|
2002
|
0.77
|
|
37
|
Neurological complications of HIV infection and AIDS: current and future perspectives.
|
J Neurovirol
|
2005
|
0.76
|
|
38
|
Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis.
|
Nucleic Acids Res
|
2013
|
0.75
|
|
39
|
The in silico macrophage: toward a better understanding of inflammatory disease.
|
Genome Med
|
2011
|
0.75
|
|
40
|
Editorial comment: déjà vu--neurologic complications of HIV infection in the expanding epidemic.
|
AIDS Read
|
2005
|
0.75
|
|
41
|
Impact of aging on neurocognitive performance in previously antiretroviral-naïve HIV+ individuals on their first suppressive regimen.
|
AIDS
|
2017
|
0.75
|
|
42
|
Possibility of charge contrast imaging of polymeric materials.
|
Scanning
|
2004
|
0.75
|
|
43
|
Enhancement of PAH biomineralization rates by cyclodextrins under Fe(III)-reducing conditions.
|
Chemosphere
|
2005
|
0.75
|